Industry News
Pharmaceutical Industry News
Sanofi, Regeneron’s Dupixent tops TV spending again, with AbbVie’s Rinvoq close behind
Sanofi, Regeneron's Dupixent tops TV spending again, with AbbVie's Rinvoq close behind bbulik Wed, 09/08/2021 - 16:47
No joy for Ajovy: Teva’s migraine drug can’t find a win in meta-analysis versus Biohaven, AbbVie meds
No joy for Ajovy: Teva's migraine drug can't find a win in meta-analysis versus Biohaven, AbbVie meds nhigginsdunn Wed, 09/08/2021 - 15:30
No joy for Ajovy: Teva’s migraine drug can’t find a convincing win in meta-analysis versus Biohaven, AbbVie meds
No joy for Ajovy: Teva's migraine drug can't find a convincing win in meta-analysis versus Biohaven, AbbVie meds nhigginsdunn Wed, 09/08/2021 - 15:30
As Congress considers drug price reforms, Merck, Lilly and Takeda execs warn of dire consequences
As Congress considers drug price reforms, Merck, Lilly and Takeda execs warn of dire consequences kdunleavy Wed, 09/08/2021 - 11:26
GSK, Pfizer and Johnson & Johnson race toward $10B+ RSV vaccine market: analyst
GSK, Pfizer and Johnson & Johnson race toward $10B+ RSV vaccine market: analyst esagonowsky Wed, 09/08/2021 - 10:39
GSK, Pfizer and Johnson & Johnson race toward $10B-plus RSV vaccine market: analyst
GSK, Pfizer and Johnson & Johnson race toward $10B-plus RSV vaccine market: analyst esagonowsky Wed, 09/08/2021 - 10:39
Moderna taps National Resilience’s new Canadian manufacturing site for COVID-19 vaccine production duties
Moderna taps National Resilience's new Canadian manufacturing site for COVID-19 vaccine production duties nhigginsdunn Wed, 09/08/2021 - 09:49
MacroGenics’ breast cancer drug Margenza erases edge over Herceptin as it fails to extend life
MacroGenics' breast cancer drug Margenza erases edge over Herceptin as it fails to extend life aliu Wed, 09/08/2021 - 09:17
Another discount does the trick: Johnson & Johnson wins NICE backing for prostate cancer drug Erleada
Another discount does the trick: Johnson & Johnson wins NICE backing for prostate cancer drug Erleada kdunleavy Wed, 09/08/2021 - 09:12
On a dealmaking roll, Sanofi lays out $1.9B for Kadmon and its newly launched transplant drug
On a dealmaking roll, Sanofi lays out $1.9B for Kadmon and its newly launched transplant drug aliu Wed, 09/08/2021 - 07:43
Science, science and more science: Pfizer and digital partners work to meet doctor demand for deep-dive data
Science, science and more science: Pfizer and digital partners work to meet doctor demand for deep-dive data bbulik Tue, 09/07/2021 - 23:47
Citius buys out license to Ontak replacement from Dr. Reddy’s for $40M
Citius buys out license to Ontak replacement from Dr. Reddy's for $40M aarmstrong Tue, 09/07/2021 - 14:53
Ohio Judge Reverses Order Requiring Covid Patient to Be Given Ivermectin
An intubated patient was prescribed the deworming drug by his doctor. Federal health officials have said that it has not been shown to be effective against the coronavirus and that it can be toxic in
Teligent pulls ‘super potent’ topical lidocaine lot following failed stability tests
Teligent pulls 'super potent' topical lidocaine lot following failed stability tests nhigginsdunn Tue, 09/07/2021 - 11:46
Impel gets FDA nod to challenge Bausch for migraine market
Impel gets FDA nod to challenge Bausch for migraine market ntaylor Tue, 09/07/2021 - 10:46
Roche’s Polivy to hit $2.4B as doctors expect ‘significant switching’ in newly diagnosed lymphoma: analyst
Roche's Polivy to hit $2.4B as doctors expect 'significant switching' in newly diagnosed lymphoma: analyst aliu Tue, 09/07/2021 - 10:43
Intarcia faces FDA refusal to approve as push to get diabetes delivery system to market enters endgame
Intarcia faces FDA refusal to approve as push to get diabetes delivery system to market enters endgame ntaylor Tue, 09/07/2021 - 10:42
Bristol Myers, Pfizer score another win in their Eliquis patent defense, protecting the blockbuster until 2028
Bristol Myers, Pfizer score another win in their Eliquis patent defense, protecting the blockbuster until 2028 esagonowsky Tue, 09/07/2021 - 09:58
After Moderna contamination mess, Takeda strikes deal with Japan to supply Novavax COVID-19 vaccines
After Moderna contamination mess, Takeda strikes deal with Japan to supply Novavax COVID-19 vaccines kdunleavy Tue, 09/07/2021 - 09:53
Digital venture shines light on the pharma prescribing power of nurse practitioners and physician assistants
Digital venture shines light on the pharma prescribing power of nurse practitioners and physician assistants sharon.coey Tue, 09/07/2021 - 08:44